Premier Biotech, Inc. of Minneapolis, MN at MEDICA 2021 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option

Premier Biotech, Inc.

723, Kasota avenue se, 55414 Minneapolis, MN
USA

Submit your contact details

Provide your contact details to the exhibitor. Optionally, you may also add a personal message.

Please log in

You must be logged in to send the contact request.

An error has occurred

Please check your internet connection or try again later.

Message has been sent

Your message to the exhibitor was sent successfully.

Hall map

MEDICA 2021 hall map (Hall 16): stand A17

Fairground map

MEDICA 2021 fairground map: Hall 16

Visit us

Hall 16 / A17

15 Nov 2021

Topic

all-day

Come Visit Premier Biotech

Premier Biotech welcomes you to visit them at MEDICA Tradefair 2021 to see their new drug testing products including Oral Detect, the next innovation in rapid saliva roadside drug testing. 

More Less

16 Nov 2021

Topic

all-day

Come Visit Premier Biotech

Premier Biotech welcomes you to visit them at MEDICA Tradefair 2021 to see their new drug testing products including Oral Detect, the next innovation in rapid saliva roadside drug testing. 

More Less

17 Nov 2021

Topic

all-day

Come Visit Premier Biotech

Premier Biotech welcomes you to visit them at MEDICA Tradefair 2021 to see their new drug testing products including Oral Detect, the next innovation in rapid saliva roadside drug testing. 

More Less

18 Nov 2021

Topic

all-day

Come Visit Premier Biotech

Premier Biotech welcomes you to visit them at MEDICA Tradefair 2021 to see their new drug testing products including Oral Detect, the next innovation in rapid saliva roadside drug testing. 

More Less

Our products

Product category: Immuno assay testing

Oral Detect - Saliva (oral fluid) rapid, roadside drug test

The next innovation in roadside impairment testing, Oral Detect provides a compact design offering actionable, observed oral fluid collection for the detection of up to 12 drugs in minutes, including: ∆9-THC, Cocaine/BZE, Opiates class, Heroin-specific, Methamphetamine/MDMA, Oxycodone, Benzodiazepines, Buprenorphine, Methadone, Amphetamine, Fentanyl and Barbiturates.

More Less

Product category: Immuno assay testing

OralTox - FDA 510(k) Cleared Rapid Oral Fluid Drug Test

Truly in a league of its own, Premier Biotech’s flagship rapid oral fluid device OralTox continues to evolve. OralTox is FDA 510(k) Cleared for the following 8 drugs: Amphetamine, Cocaine, Marijuana, Methadone, Methamphetamine, Opiates, Oxycodone (ONLY rapid oral fluid device to contain OXY) and Phencyclidine. OralTox provides a non-invasive, 100% observed testing solution while delivering results in just minutes. When timing is critical, OralTox allows collectors to action immediately with accurate results in just minutes. When confirmation testing is required (presumptive positive results), OralTox once again stands out as the only FDA 510(k) Cleared rapid oral fluid device able to be sent to the lab for confirmation testing without requiring a second sample.

More Less

Product category: Immuno assay testing

Premier Biotech COVID-19 IgG/IgM Rapid Test Cassette

The Premier Biotech COVID-19 IgG/IgM Rapid Test Cassette is a lateral flow immunochromatographic assay for the detection of SARS-CoV-2 antibodies in venous whole blood, serum or plasma. The COVID-19 IgG/IgM Rapid Test Cassette is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.

Statements And Conditions:
This test has been authorized by FDA under an EUA for use by authorized laboratories;
This test has not been FDA cleared or approved;
This test has been authorized only for the presence of lgM and IgG antibodies against SARS-CoV-2, not for any other viruses or pathogens;
This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(l) of the Act, 21 U.S.C. § 360bbb-3(b)(l), unless the authorization is terminated or revoked sooner.
This product is not for home use (Emergency Use Authorization – In Vitro Diagnostic Use Only)
Not for screening of donated blood

More Less

Product category: Immuno assay testing

COVID-19 Antigen Test

COVID-19 Antigen Test is a lateral flow immunochromatographic assay for the detection of extracted
nucleocapsid protein antigens specific to SARS-CoV-2 in swab specimens directly collected from individuals who are suspected of
COVID-19 by their healthcare providers.

  • Identify individual’s current infection status to COVID-19
  • Fast and easy to use in Point-of-Care setting
  • Qualitatively detect the SARS-CoV2 nucleocapsid protein
  • Lateral flow assay
  • Use nasopharyngeal (NIP) and nasal swab specimens
  • Intended at POC setting (i.e., in patient care settings) by medical professionals operating under a CLIA Certificate of Waiver
  • Reliable results in only 10 minutes
  • No special equipment or training required
  • All-in-one package including collection swabs
  • High sensitivity (90%) and specificity (100%)

More Less

Product category: Immuno assay testing

Premier Identification Kit

The new solution for presumptive field-testing for suspicious substances (drugs of abuse/narcotics, paraphernalia). Using state-of-the-art chemistry, the Premier Identification Kit offers a convenient, easy to use procedure that presumptively identifies the most commonly encountered narcotic and street drugs quickly. With collector safety at the forefront of its design, substances can be quickly identified while remaining contained within its multi-function collector/dropper alleviating direct contact. Suspect materials are also preserved for legal proceedings.

More Less

Product category: Immuno assay testing

Premier Bio-Cup

Our rapid, integrated test cups are distinguished by their accuracy, fast results, ease of use, and options for customized panels. While many companies offer a limited portfolio that mirrors the same testing panels that have remained unchanged for years, Premier Biotech has created an innovative portfolio that includes tests for relevant drugs of abuse. Available detection panels for fentanyl, tramadol, buprenorphine, oxycodone, 6-AM, EtG, K2(spice) and more. We provide our customers with solutions that allow for visibility into drug use that would have gone undetected as a result of an ineffective and dated testing panel.

More Less

Product category: Immuno assay testing

Premier Bio-Dip

Our rapid, single and multi-strip Premier Bio-Dip® is distinguished by its accuracy, fast results, and overall product quality. While many companies take a one size fits all approach and offer a limited portfolio, we include relevant panel options that continue to evolve. Premier Bio-Dip configurations can include tests for fentanyl, tramadol, buprenorphine, oxycodone, EtG and many more. Our innovative portfolio has provided customers with solutions that allow for visibility into drug use that previously went undetected as a result of ineffective and dated testing panels.

More Less

Company news

Date

Topic

06 Oct 2021

The Future of Drug Testing: Oral Fluid Testing and the Importance of a Rapid Result

The legalization of marijuana coupled with the devasting impact of the COVID-19 pandemic have led to an overall increase in substance abuse, more positive drug tests in the workplace, and a rise in marijuana-related traffic accidents and fatalities.

The need for drug testing, particularly a rapid-result test that is easy to collect and can detect recent use, has never been more critical...

More Less

06 Oct 2021

FDA Grants EUA to Rapid COVID-19 Antibody Testing Product Distributed by Premier Biotech

MINNEAPOLIS, June 9, 2020 /PRNewswire/ -- Premier Biotech, Inc. ("Premier Biotech" or "the Company") announced today that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) to the COVID-19 IgG and IgM rapid test manufactured by Hangzhou Biotest Biotech, Co., Ltd. ("Biotest") and distributed by Premier Biotech, used for the qualitative detection and differentiation of IgM and IgG antibodies against SARS-CoV-2 in whole blood, serum, or plasma. The product includes a complete testing kit that produces reliable results in 10 minutes.

"The FDA's decision to grant Biotest's product EUA is great news for communities across the U.S. that continue to struggle to access adequate COVID-19 testing, which healthcare experts agree is essential to successful recovery from the COVID-19 crisis," said Premier Biotech CEO Todd Bailey. "Premier Biotech is proud to leverage our national distribution expertise and relationship with Biotest to provide U.S. healthcare professionals and their patients access to fast, reliable antibody testing."

"As the grant of EUA confirms, the National Cancer Institute has verified this product exceeds the 95% specificity and 90% sensitivity standards set by the FDA. Undoubtedly, this product is in clear alignment with Premier Biotech's rigorous compliance standards and commitment to distributing high-quality testing solutions. We will continue to follow the regulatory guidelines closely as we distribute the product for emergency use to authorized laboratories nationwide."

About Premier Biotech Inc.

Premier Biotech Inc. is a leading provider of rapid drug testing devices and distributor of a COVID-19 antibody testing product that has been granted Emergency Use Authorization by the U.S. Food and Drug Administration. The company offers a comprehensive line of proprietary drug testing products. Premier Biotech Labs, LLC, located in Minneapolis, provides high complexity testing and customized laboratory services for toxicology testing in criminal justice/corrections, clinical medication monitoring; and corporate workforce clients. Premier Biotech Labs holds both CAP (College of American Pathologists) Forensic accreditation and Clinical Laboratory Improvement Amendments (CLIA) certification, each of which requires the highest level of quality control standards and rigorous protocol adherence, including complete chain of custody and frequent inspections.  More information at www.premierbiotech.com

More Less

About us

Company portrait

Premier Biotech is a leading USA based drug testing company delivering the highest quality and innovative rapid saliva (oral fluid), urine, and COVID-19 (antibody, antigen) products and solutions. Premier Biotech's commitment is to continually change the game in drugs of abuse testing by proactively addressing the ever-changing trends in substance abuse while bringing new and products and services to market.

Specialties:
  • Saliva Roadside Drug Testing - Police (Law Enforcement)
  • First-To-Market Technology
  • Rapid Point of Care Drug Testing Products
  • COVID-19 (Antibody, Antigen) Tests
  • Lab Accuracy Results Without an Instrument
  • Rapid urine cups and dips
Products:
  • Oral Detect: Saliva (oral fluid) rapid, roadside drug test
  • OralTox: FDA 510(k) Cleared - Saliva (Oral Fluid) Rapid Test
  • OT-Scan: Automated result interpretation and reporting
  • Rapid COVID-19 (Antibody, Antigen) Tests
  • PIK: The new solution for presumptive field-testing
  • Premier Bio-Cup/Dip: Rapid urine cup and dips with extensive drugs/panels
Values:
  • Quality Products and Innovative Solutions
  • First-To-Market with Cutting-edge Technology
  • Flexible, Customized Configurations
  • Highest Standards in Accuracy, Reliability and Specificity
  • Exceptional Customer Service
  • Continued Education and Best Practices
Premier Biotech, Inc. (USA)
Phone: 888-686-9909
Web: www.premierbiotech.com

Company data

Area of business Diagnostic tests

Company information as a PDF file